Search Results for keywords:"artificial intelligence"

The Department of Energy is inviting public input on autonomous experimentation platforms as part of the Material Genome Initiative. This request for information (RFI) aims to gather comments on developing these platforms to enhance materials research and development, focusing on aspects like laboratory automation, artificial intelligence, and robotics. Responses, which must be submitted by March 21, 2025, should address several areas, including infrastructure mapping, partnership models, workforce development, and the integration of scientific equipment. Additionally, the RFI stresses the importance of not including confidential business information in public submissions.

The Bureau of Industry and Security (BIS) has issued a final rule adding 11 Chinese companies, mostly involved in advanced artificial intelligence and lithography technologies, to the Entity List. This means they require a U.S. export license due to concerns that they contribute to military advancements that oppose U.S. national security and foreign policy interests. The rule also modifies an entry for India, removing specific entities to support U.S.-India energy cooperation, particularly in nuclear technology. The changes went into effect on January 16, 2025.

The Department of Health and Human Services (HHS) has issued a final rule that requires its regulations to be reviewed periodically, with most regulations set to expire automatically every ten years unless reviewed. This is intended to ensure that regulations stay up-to-date and relevant. The final rule also includes processes for public comments and specifies the criteria for reviews, which include assessing whether the regulations significantly impact small entities, and if they are still necessary or need amendments. Certain regulations, such as those mandated by federal law and the annual Medicare payment update rules, are exempt from these reviews.

The U.S. Artificial Intelligence Safety Institute (AISI), part of the National Institute of Standards and Technology (NIST) under the Department of Commerce, is asking for public comments on an updated draft document titled Managing Misuse Risk for Dual-Use Foundation Models. This draft is an update related to Executive Order 14110, which emphasizes the safe, secure, and trustworthy use and development of AI. The document, identified as NIST AI 800-1, includes new guidelines for handling risks associated with chemical, biological, and cyber misuse. Comments are due by March 15, 2025, and can be submitted online through specified platforms or by email.

The Securities and Exchange Commission (SEC) is holding a public roundtable on artificial intelligence in the financial industry. This event will take place on March 27, 2025, at the SEC's headquarters in Washington, DC, starting at 9 a.m. The roundtable aims to gather insights from market participants, academics, and industry professionals regarding the risks, benefits, and governance of AI in the financial sector. The meeting will be open to the public with first-come, first-served seating, and will also be webcast on the SEC's website.

The Food and Drug Administration (FDA) has announced the availability of draft guidance for devices that use artificial intelligence (AI)-enabled software functions. This draft guidance, once finalized, will give recommendations for what should be included in marketing submissions, focusing on safety and effectiveness. It suggests a total product lifecycle (TPLC) approach, which considers the design, development, and implementation stages of AI-enabled devices. Public comments on this draft are sought to ensure that FDA’s guidance aligns with the fast-evolving field of AI and adequately addresses performance and risk concerns.

The Administrative Conference of the United States (ACUS) held its virtual Seventy-third Plenary Session, during which it adopted six recommendations and issued one official statement. The recommendations cover a range of topics including rules on rulemakings, protecting sensitive materials in public rulemaking dockets, improving government contract bid protest procedures, and making agency appellate systems more efficient. The official statement addresses the use of artificial intelligence by agencies, highlighting the importance of transparency and oversight. While these recommendations are not binding, they are intended to improve processes within federal agencies and will be shared with affected entities such as Congress and the Judicial Conference of the United States.

The U.S. Copyright Office has released an update to its Compendium of U.S. Copyright Office Practices, Third Edition. This updated version includes a variety of changes and revisions. It reflects new actions taken since 2017, updates procedures in line with recent court decisions, and revises language to clarify the registration and application processes for copyright. Additionally, it includes changes to group registration for various works, revises procedures for example, group photographs, unpublished works, and introduces new topics like artificial intelligence in copyright.

The Food and Drug Administration (FDA) has released a final guidance document on marketing submissions for devices with artificial intelligence-enabled software. This guidance provides recommendations for including a Predetermined Change Control Plan (PCCP) in submissions, which outlines planned AI software modifications, their development and validation, and their potential impact. The FDA aims to streamline the approval process for such modifications by avoiding repeated marketing submissions while ensuring device safety and effectiveness. The guidance reflects the FDA's efforts to regulate AI-enabled medical device software innovatively and effectively.

The Securities and Exchange Commission (SEC) is holding a public meeting of its Investor Advisory Committee on Thursday, March 6, 2025, at 10:00 a.m. (ET). This meeting will be both in-person at their headquarters in Washington, DC, and available online. The meeting will cover topics like artificial intelligence's impact on operations, retail investor fraud in America, and recommendations about investor claims under the Securities Act of 1933. People are invited to submit their written statements before March 5, 2025, using the file number 265-28.